New drug ENX-205 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This study tests a new drug, ENX-205, in 60 healthy adults to see if it is safe and how the body processes it. Participants receive a single dose and are monitored for side effects. Some also get a brain scan to see where the drug goes. This is early research with no direct healt…
Phase: PHASE1 • Sponsor: Engrail Therapeutics INC • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC